Home > Insider Trading > Filing (0001104659-21-001582)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1554859	Semler Scientific Inc.	SMLR	Electromedical & Electrotherapeutic Apparatus (3845)	261367393

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1594342	Douglas Murphy-Chutorian	C/O Semler Scientific, Inc. 2340-2348 Walsh Avenue, Suite 2344 Santa Clara CA 95051	Chief Executive Officer	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-01-04	100	$89.00	57,221	No	4	S	Indirect	By Trust
Common Stock	Disposition	2021-01-04	600	$90.35	56,621	No	4	S	Indirect	By Trust
Common Stock	Disposition	2021-01-04	450	$91.16	56,171	No	4	S	Indirect	By Trust
Common Stock	Disposition	2021-01-04	100	$93.20	56,071	No	4	S	Indirect	By Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Trust
No	4	S	Indirect	By Trust
No	4	S	Indirect	By Trust
No	4	S	Indirect	By Trust

Footnotes

Shares sold pursuant to a 10b5-1 trading plan.
Shares are held by the Murphy-Chutorian Family Trust U/D/T dated January 13, 1997, of which the Reporting Person is co-Trustee with his spouse.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.00 to $90.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.01 to $91.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4.